SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.54 HKD | -3.57% |
|
+3.85% | -16.92% |
| 09:37am | Sihuan Pharmaceutical Unit Gets Nod for Weight-Loss Drug Application in China | MT |
| 06-13 | Sihuan Pharma Subsidiary Licenses Fadanafil Drug to Livzon Pharmaceutical Unit | MT |
Sihuan Pharmaceutical Holdings Group Ltd is a holding company mainly engaged in pharmaceutical manufacturing business. The Company operates three segments. Medical Aesthetic Products segment includes the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care and others to provide non- or minimally invasive medical aesthetics comprehensive solutions. Innovative Medicine and Other Medicine segment is engaged in the research and development of innovative drugs in the fields of digestion, oncology, non-alcoholic hepatitis, diabetes and complications. The Company also operates Generic Medicine segment.
Sector
Pharmaceuticals
Calendar
2024-08-26
- Q2 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -16.92% | 665M | |
| +52.81% | 791B | |
| +40.45% | 630B | |
| +17.05% | 328B | |
| +9.16% | 298B | |
| +17.25% | 246B | |
| +0.41% | 225B | |
| +10.22% | 218B | |
| +4.36% | 160B | |
| -6.44% | 156B |
- Stock Market
- Equities
- 460 Stock
- News Sihuan Pharmaceutical Holdings Group Ltd.
- Sihuan Pharmaceutical, Unit Withdraw Latter's Stock Exchange Bid, Shares Down by Over 3%
